Chatzikalil E, Arvanitakis K, Filippatos F, Diamantopoulos P, Koufakis T, Solomou E
Cancers (Basel). 2025; 17(4).
PMID: 40002226
PMC: 11853134.
DOI: 10.3390/cancers17040631.
Guo Y, Ma M, Tian T, Zhang J, Guo X, Qiao S
Oncol Lett. 2024; 28(4):468.
PMID: 39119236
PMC: 11306990.
DOI: 10.3892/ol.2024.14601.
Guglielmi V, Lam D, DAngelo M
Sci Adv. 2024; 10(23):eadn8963.
PMID: 38838144
PMC: 11152124.
DOI: 10.1126/sciadv.adn8963.
Yu W, Rush C, Tingey M, Junod S, Yang W
Chem Biomed Imaging. 2023; 1(4):356-371.
PMID: 37501792
PMC: 10369678.
DOI: 10.1021/cbmi.3c00036.
Li T, Zhang G, Zhang X, Lin H, Liu Q
Front Oncol. 2022; 12:1015792.
PMID: 36408177
PMC: 9669583.
DOI: 10.3389/fonc.2022.1015792.
Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway.
Zhang X, Wang F, Yan F, Huang D, Wang H, Gao B
Cancer Cell Int. 2022; 22(1):40.
PMID: 35081975
PMC: 8793161.
DOI: 10.1186/s12935-022-02451-y.
[Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement: 5 cases report and literatures review].
Liu Y, Zhao J, Feng J, Li Q, Chen Y, Qiu L
Zhonghua Xue Ye Xue Za Zhi. 2019; 40(10):848-852.
PMID: 31775485
PMC: 7364987.
DOI: 10.3760/cma.j.issn.0253-2727.2019.10.010.
The SUMO Pathway in Hematomalignancies and Their Response to Therapies.
Boulanger M, Paolillo R, Piechaczyk M, Bossis G
Int J Mol Sci. 2019; 20(16).
PMID: 31405039
PMC: 6721055.
DOI: 10.3390/ijms20163895.
Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
Qiu X, Li F, Cao H, Shao J, Mei J, Li H
Mol Med Rep. 2017; 15(3):1024-1030.
PMID: 28138694
PMC: 5367333.
DOI: 10.3892/mmr.2017.6140.
[Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
Zhou F, Chen S, Chao H, Zhang R, Zhou M, Pan J
Zhonghua Xue Ye Xue Za Zhi. 2015; 36(4):291-6.
PMID: 25916288
PMC: 7342628.
DOI: 10.3760/cma.j.issn.0253-2727.2015.04.006.
The Fibroblast Growth Factor signaling pathway.
Ornitz D, Itoh N
Wiley Interdiscip Rev Dev Biol. 2015; 4(3):215-66.
PMID: 25772309
PMC: 4393358.
DOI: 10.1002/wdev.176.
A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation.
Nakamura Y, Ito Y, Wakimoto N, Kakegawa E, Uchida Y, Bessho M
Blood Cancer J. 2014; 4:e265.
PMID: 25501022
PMC: 4315892.
DOI: 10.1038/bcj.2014.86.
Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
Duckworth C, Zhang L, Li S
Int J Clin Exp Pathol. 2014; 7(2):801-7.
PMID: 24551307
PMC: 3925931.
inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)-ALK fusion gene in myeloid leukemia that developed in an elderly woman.
Maesako Y, Izumi K, Okamori S, Takeoka K, Kishimori C, Okumura A
Int J Hematol. 2013; 99(2):202-7.
PMID: 24307515
DOI: 10.1007/s12185-013-1482-x.
